Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPirini, Francesca
dc.contributor.authorRodriguez-Torres, Sebastian
dc.contributor.authorAyandibu, Bola Grace
dc.contributor.authorOrera-Clemente, María
dc.contributor.authorGonzalez-de la Vega, Alberto
dc.contributor.authorLawson, Fahcina
dc.contributor.authorThorpe, Roland J
dc.contributor.authorSidransky, David
dc.contributor.authorGuerrero-Preston, Rafael
dc.identifier.citationMol Med Rep.2018 Jan;(17)1:1699-1709
dc.description.abstractSingle nucleotide polymorphisms associated with lipid metabolism and energy balance are implicated in the weight loss response caused by nutritional interventions. Diet‑induced weight loss is also associated with differential global DNA methylation. DNA methylation has been proposed as a predictive biomarker for weight loss response. Personalized biomarkers for successful weight loss may inform clinical decisions when deciding between behavioral and surgical weight loss interventions. The aim of the present study was to investigate the association between global DNA methylation, genetic variants associated with energy balance and lipid metabolism, and weight loss following a non‑surgical weight loss regimen. The present study included 105 obese participants that were enrolled in a personalized weight loss program based on their allelic composition of the following five energy balance and lipid metabolism‑associated loci: Near insulin‑induced gene 2 (INSIG2); melanocortin 4 receptor; adrenoceptor β2; apolipoprotein A5; and G‑protein subunit β3. The present study investigated the association between a global DNA methylation index (GDMI), the allelic composition of the five energy balance and lipid metabolism‑associated loci, and weight loss during a 12 month program, after controlling for age, sex and body mass index (BMI). The results demonstrated a significant association between the GDMI and near INSIG2 locus, after adjusting for BMI and weight loss, and significant trends were observed when stratifying by gender. In conclusion, a combination of genetic and epigenetic biomarkers may be used to design personalized weight loss interventions, enabling adherence and ensuring improved outcomes for obesity treatment programs. Precision weight loss programs designed based on molecular information may enable the creation of personalized interventions for patients, that use genomic biomarkers for treatment design and for treatment adherence monitoring, thus improving response to treatment.
dc.subject.meshGene Frequency
dc.subject.meshGenetic Association Studies
dc.subject.meshIntracellular Signaling Peptides and Proteins
dc.subject.meshMembrane Proteins
dc.subject.meshMiddle Aged
dc.subject.meshPolymorphism, Single Nucleotide
dc.subject.meshTreatment Outcome
dc.subject.meshWeight Loss
dc.subject.meshWeight Reduction Programs
dc.subject.meshYoung Adult
dc.subject.meshDNA Methylation
dc.titleINSIG2 rs7566605 single nucleotide variant and global DNA methylation index levels are associated with weight loss in a personalized weight reduction program.
dc.identifier.journalMolecular medicine reports
dc.pubmedtypeJournal Article
Appears in Collections:Fundaciones e Institutos de Investigación > IIS H. General U. Gregorio Marañón > Artículos

Files in This Item:
File Description SizeFormat 
PMC5780113.pdf1.02 MBAdobe PDFThumbnail

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.